• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025

    4/10/25 5:00:00 PM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary
    Get the next $EVH alert in real time by email

    Company to Participate in Upcoming Conferences

    WASHINGTON, April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after market close, with a conference call to follow at 5 p.m. ET.

    Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.

    Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.

    An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.

    Upcoming Investor Events

    Additionally, Evolent announced that its executive management team will participate in upcoming investor conferences.



    A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.   

    • Needham 20th Annual Technology, Media and Consumer Conference to be held virtually on May 12, 2025.
    • RBC Global Health Care Conference at Intercontinental Barclay in New York, New York on May 21, 2025.
    • William Blair 45th Annual Growth Stock Conference at the Lowes Hotel in Chicago, Illinois on June 3, 2025.
    • The Citizens JMP Medical Devices and Healthcare Services Forum at the Boston Harbor Hotel in Boston, Massachusetts on June 17, 2025.

     

    Evolent Health Logo (PRNewsfoto/Evolent Health)

    About Evolent 



    Evolent (NYSE:EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.

    Contacts:

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-first-quarter-2025-financial-results-on-thursday-may-8-2025-302425889.html

    SOURCE Evolent Health, Inc.

    Get the next $EVH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EVH

    DatePrice TargetRatingAnalyst
    1/10/2025$15.00Buy
    Needham
    12/3/2024$36.00 → $29.00Buy
    BTIG Research
    11/8/2024$38.00 → $16.00Overweight → Equal-Weight
    Stephens
    10/11/2024$35.00Overweight
    KeyBanc Capital Markets
    8/9/2024$28.00 → $33.00Hold → Buy
    Truist
    4/22/2024$40.00Buy
    Citigroup
    3/1/2024$45.00Outperform
    Oppenheimer
    1/3/2024$39.00Overweight
    Barclays
    More analyst ratings

    $EVH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Guertin Shawn M was granted 21,979 shares (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      6/9/25 7:18:32 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • New insider Guertin Shawn M claimed no ownership of stock in the company (SEC Form 3)

      3 - Evolent Health, Inc. (0001628908) (Issuer)

      6/9/25 7:17:22 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Director Jelinek Richard M was granted 21,979 shares, increasing direct ownership by 152% to 36,437 units (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      6/9/25 7:14:47 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    SEC Filings

    See more
    • Evolent Health Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Evolent Health, Inc. (0001628908) (Filer)

      6/20/25 6:32:06 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 filed by Evolent Health Inc

      S-8 - Evolent Health, Inc. (0001628908) (Filer)

      6/10/25 5:21:58 PM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Evolent Health Inc filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Evolent Health, Inc. (0001628908) (Filer)

      6/5/25 4:55:52 PM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Evolent Health with a new price target

      Needham initiated coverage of Evolent Health with a rating of Buy and set a new price target of $15.00

      1/10/25 7:49:47 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • BTIG Research reiterated coverage on Evolent Health with a new price target

      BTIG Research reiterated coverage of Evolent Health with a rating of Buy and set a new price target of $29.00 from $36.00 previously

      12/3/24 7:52:53 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Evolent Health downgraded by Stephens with a new price target

      Stephens downgraded Evolent Health from Overweight to Equal-Weight and set a new price target of $16.00 from $38.00 previously

      11/8/24 7:50:07 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Holder Diane bought $25,518 worth of shares (2,735 units at $9.33), increasing direct ownership by 4% to 70,584 units (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      3/10/25 8:20:54 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • PRESIDENT Mccarthy Daniel Joseph bought $99,470 worth of shares (11,040 units at $9.01), increasing direct ownership by 3% to 389,004 units (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      3/10/25 8:18:12 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Director Jelinek Richard M bought $273,750 worth of shares (30,000 units at $9.12) (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      3/10/25 8:16:20 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    Press Releases

    Fastest customizable press release news feed in the world

    See more